Opportunity for the HORIZON-CL4-2022-DIGITAL-EMERGING-02-19 funding call

2D materials-based devices and systems for biomedical applications (RIA)


November 16, 2022

Project types:

  1. HORIZON-RIA HORIZON Research and Innovation Actions

Project Proposal

The call HORIZON-CL4-2022-DIGITAL-EMERGING-02-19 has been scheduled to close, so this opportunity is no longer current.

Elvesys is currently partnering in a proposal led by the Luxembourg Institute of Technology. We are looking for a partner to complete our consortium:

Our objective is to produce a protein sequencer with better resolution and sensitivity than current Mass Spectrometry (MS). Our device would not have the same throughput than MS to detect biomarkers known for example from a database (biomarkers for which MS/e is known) but we would be able to sequence ex-novo proteins and for example, detect the sites of post-translational modifications using a cost-effective device.

We currently have a strong consortium of material scientist, people working in the biosensing community and in protein production that have an advance draft of the proposal.

We are looking for a partner with a clinical application that could take advantage from our device to mount a case study with proven clinical relevance where our device would have an advantage to provide an application, which today cannot be done with current methods. Ideally the partner should be able to prepare the protein assay with smart digestion and purification of the proteins to isolate peptides of ~30 amino acids whit the relevant fragment to sequence.